Valye reports for unlimited access

Wellgistics Health, Inc. is a healthcare technology company focused on improving pharmaceutical supply chain transparency, patient access, and cost efficiency in the US market. The company provides pharmacy benefit management services, digital health solutions, and collaborates with partners to distribute and promote healthcare products and services. Wellgistics has formed strategic partnerships and joint ventures, including a notable collaboration with Kare PharmTech to commercialize benefits verification products. The company also engages in initiatives to enhance healthcare infrastructure, such as implementing blockchain-based payment solutions and marketing novel medical foods addressing specific health conditions. Leadership includes experienced executives with backgrounds in pharmacy, healthcare technology, and finance. The company is publicly traded on NASDAQ and files regular reports with the SEC.

Cisco Systems Inc operates in the communication equipment industry, providing networking hardware, software, and services. The company serves diverse customer segments including service providers, cloud customers, and enterprises. Cisco's business is subject to fluctuations in demand, supply chain challenges, and competitive pressures from global and regional players. The company manages inventory and supply chain risks through purchase commitments and supplier agreements. Cisco is focusing on growth areas such as AI, cloud computing, and cybersecurity, aligning its product portfolio and investments accordingly. The company maintains a stock repurchase program and has a significant presence in global markets, facing risks from geopolitical and economic uncertainties.

Red Robin Gourmet Burgers, Inc. is a Delaware corporation operating casual dining restaurants primarily in North America. The company is known for its gourmet burgers served with Bottomless Steak Fries and a variety of sides in a fun, family-friendly environment. Founded in 1969, Red Robin operates 475 restaurants as of the end of 2025, with 385 company-owned and 90 franchised locations. The menu includes over 20 burger varieties, including beef, chicken, turkey, vegetarian, and plant-based options, alongside other American favorites, desserts, and beverages. The company emphasizes customization, quality, and value, with an average guest check of $18.76 in fiscal 2025. Red Robin's strategic plan, 'First Choice,' launched in 2025, focuses on operational efficiency, marketing to drive traffic, expense management, restaurant improvements, and talent development. The company maintains rigorous food safety standards and engages in data-driven marketing. It also operates a partnership with Donatos® pizza in select locations. Financially, the company reported a net loss and liquidity challenges in Q1 2026, with ongoing efforts to refinance debt and improve financial performance.

Lakeside Holding Ltd, founded in 2018 and headquartered in Chicago, Illinois, is an Asian American-owned business specializing in integrated cross-border supply chain solutions with a strategic focus on the Asian market, including China and South Korea. The company provides customized cross-border ocean and air freight solutions tailored to customer needs for transporting goods into the U.S. Its services encompass freight consolidation and forwarding, customs clearance, warehousing and distribution, and U.S. domestic ground transportation. Lakeside operates three major regional warehousing and distribution centers in Illinois and Texas, with a combined area of approximately 142,484 square feet and 52 docks, supporting a daily freight volume of up to 3,000 cubic meters. The company collaborates with a broad network of over 150 warehouses and distribution terminals and more than 200 domestic ground transportation carriers. In late 2024, Lakeside expanded into pharmaceutical distribution through the acquisition of Hupan Pharmaceutical, based in Wuhan, China. The company leverages proprietary technology platforms to optimize logistics operations and maintains a workforce of 94 full-time employees as of mid-2025.

Oramed Pharmaceuticals Inc. develops orally ingestible drug delivery technologies, primarily focusing on oral insulin capsules and other biologics. The company has transitioned its POD platform and oral insulin program to Lifeward, a medical robotics and rehabilitation company, in exchange for a near 50% ownership stake, aligning Oramed with Lifeward's commercial portfolio and recurring revenue streams. Oramed continues to manage clinical trials for the oral insulin product through its subsidiary OraTech. Additionally, Oramed holds a significant equity position in Alpha Tau, which is advancing a novel alpha-radiation cancer therapy platform (Alpha DaRT) through multiple clinical trials and has received regulatory approval in Japan. Oramed's financial position includes cash, short-term investments, and marketable securities, with a history of net losses but recent net income driven by investment revaluations. The company faces operational risks related to personnel, joint ventures, regulatory approvals, and market conditions.

Akari Therapeutics Plc is a biotechnology company specializing in the development of next-generation antibody-drug conjugates (ADCs) for oncology. Its proprietary PH1 payload targets RNA splicing by modulating the spliceosome, leading to cancer cell death and immune system activation. The lead ADC candidate, AKTX-101, targets the Trop-2 receptor and has shown promising preclinical efficacy and potential synergy with checkpoint inhibitors. The company is advancing AKTX-101 toward clinical trials with a planned first-in-human Phase 1 study by late 2026 or early 2027. Additionally, Akari is developing AKTX-102, an ADC targeting CEACAM5, relevant in multiple solid tumors. The company relies on third-party manufacturers for GMP production and has filed patents protecting its technology. Akari has experienced operating losses and maintains a focus on research and development, supported by strategic partnerships and recent leadership appointments.

Envirotech Vehicles, Inc. develops and deploys electrified and energy-intensive hardware systems across multiple end markets. Its commercial EV segment offers Class 2-5 electric vehicles for fleet and institutional customers, manufactured by OEMs in Asia and assembled by the company. The medical supplies segment, via Maddox Industries, produces government-contracted medical products domestically. The drone segment is developing heavy-lift industrial drones for agriculture, fire suppression, and forestry, with manufacturing planned in the U.S. The company is also advancing modular AI data infrastructure integrating power generation and high-performance computing hardware. Operations have been centralized in Houston, Texas, with expanded manufacturing and technical workforce.

Educational Development Corporation is a publicly traded company listed on NASDAQ under the ticker EDUC. The company operates with a business model that includes ownership and leasing of its headquarters and distribution facilities, as evidenced by a recent sale and leaseback transaction. It maintains liquidity through cash reserves and a revolving credit facility secured by company assets. The company reported fiscal 2026 revenues of approximately $4.18 million and a net loss of $3.11 million, with negative earnings per share. The company holds scheduled earnings calls to communicate financial results and operational updates.

Capital Southwest Corp operates as an investment company focusing on debt and equity investments in portfolio companies. The company generates income primarily through interest, dividends, fees, and other investment-related income. It manages its capital structure through borrowings under credit facilities, issuance of unsecured notes, and equity offerings via an ATM program. The company also operates two Small Business Investment Company (SBIC) subsidiaries licensed by the SBA, which provide additional leverage through SBA Debentures. Capital Southwest maintains regulatory asset coverage ratios above required minimums and manages liquidity through cash, credit facilities, and capital markets access. Operating expenses mainly consist of interest on borrowings, employee compensation, and general administrative costs. The company actively manages its portfolio with realized gains and losses from investment exits and valuations.

Linkhome Holdings Inc. operates an artificial intelligence real estate platform called HomeGPT, designed to streamline and enhance the home buying and selling process. The platform integrates AI technology with financial innovation to provide end-to-end real estate solutions including brokerage services, a Cash Offer program that enables cash purchases to improve offer competitiveness, and mortgage services. The company also offers a Flash Sell service for quick home sales and a Buy Before Sell program to facilitate home transitions. Currently focused in California, Linkhome plans to expand geographically and broaden its service offerings to include title insurance, escrow, home insurance, property management, and home maintenance services. The platform supports over 1 million active residential listings and has facilitated over $180 million in transactions as of end 2025. The company completed its IPO in July 2025 and maintains strong liquidity as of Q1 2026.

Eagle Materials Inc. is a company operating in the materials sector, with publicly available financial data from its latest fiscal year ending March 31, 2026. The company demonstrates strong liquidity with a current ratio of 3.66 and a cash ratio of 1.15. Recent news coverage focuses on its Q4 2026 earnings results, which include a decline in earnings and profit but also reports of surpassing earnings and revenue estimates for the quarter. The company’s risk factors are referenced in its prior annual report filings but are not detailed here.

DeFi Development Corp. is a publicly traded company that manages a digital asset treasury strategy centered on the Solana blockchain ecosystem and operates a commercial real estate technology platform. The digital asset treasury segment focuses on acquiring, holding, and actively managing Solana (SOL) and SOL-related digital assets, including operating Solana validators and delegating SOL to external validators to earn staking rewards. The real estate platform connects commercial mortgage and small business borrowers with lenders such as banks, credit unions, REITs, and debt funds. The company uses institutional custodians and trading counterparties like Kraken, BitGo, and Galaxy Digital to manage its digital asset holdings. It has a sales agreement to raise capital through common stock offerings to support its treasury strategy and working capital needs.

SunPower Inc. is a technology-driven solar company focused on residential solar system sales and installation for homeowners, home builders, and small to medium-sized commercial customers. The company was formerly known as Complete Solaria, rebranded in 2025, and is headquartered in Orem, Utah. SunPower operates a national network of third-party sales partners and builder partners, providing a turnkey solar solution that includes software tools, sales support, and brand identity to enable competitive sales operations. The company manages the entire customer experience from contract initiation through installation and post-installation support. SunPower has expanded its operations through acquisitions including Sunder Energy, Ambia Energy, Cobalt Power Systems, and assets from SunPower Corporation, enhancing its sales force, installation capacity, and geographic reach. The company offers financing options and battery storage solutions through partnerships, aiming to provide energy-efficient solutions that reduce energy costs and carbon footprint. Its technology platform supports large-scale operations with integrated software for design, proposals, and project management. SunPower competes with traditional utilities and other solar providers by emphasizing customer experience, pricing, and operational efficiency. The company sources key components from select suppliers and maintains quality and cost controls. Financially, SunPower reported $72.8 million in revenue and $5.25 million in net income for Q1 2026, with liquidity ratios indicating current challenges in short-term asset coverage of liabilities. The company has issued convertible senior secured notes and faces risks related to supplier dependencies, regulatory changes, and financial covenants.

SunPower Inc. is a technology-driven solar company focused on delivering energy-efficient solar solutions to residential homeowners, new home builders, and small to medium-sized commercial customers across the United States. The company originated from the merger of Complete Solar Holding Corporation and The Solaria Corporation, rebranding as SunPower in 2025. It operates a national network of third-party sales partners and builder partners, managing the full lifecycle of solar system sales and installation. SunPower has expanded its footprint through strategic acquisitions, including Sunder Energy, Ambia Energy, Cobalt Power Systems, and assets from SunPower Corporation's bankruptcy proceedings. The company leverages proprietary and third-party software platforms to support sales, project management, and customer service. Its product offerings include solar modules, inverters, racking systems, battery storage, and car chargers. SunPower emphasizes a differentiated customer experience with tailored designs, pricing, and financing options. The company competes primarily with traditional utilities and other solar providers, focusing on price competitiveness, customer service, and broad product offerings. Financially, SunPower reported $72.8 million in revenue and $5.25 million in net income for Q1 2026, with liquidity ratios indicating a current ratio of 0.71 and a cash ratio of 0.06 as of March 29, 2026.

Northann Corp. focuses on additive manufacturing technology to produce innovative vinyl flooring and building solutions under the Benchwick and SuperOak brands. The company operates a vertically integrated model encompassing product design, manufacturing, and distribution, with a manufacturing facility in South Carolina currently operating at partial capacity. Northann serves primarily the U.S. and Canadian markets through wholesale distributors, major retail supermarkets, and local contractors. The company holds a portfolio of patents and is integrating AI technologies to enhance operations and customer experience. Financially, Northann reported $4.96 million in revenue and a net loss of $2.9 million for Q1 2026, with liquidity ratios indicating moderate short-term financial flexibility. The company has a concentrated customer base and faces risks related to raw material costs, competition, and economic cycles affecting construction and remodeling.

Nextpower Inc. (formerly Nextracker Inc.) is a leading global provider of solar and energy technology solutions focused on utility-scale solar power plants. Founded in 2013, the company pioneered solar tracking systems and remains the global market leader in this segment. Its flagship NX Horizon® solar tracker system features independent row tracking, self-powered motors, and a mechanically balanced design that enhances energy production, reliability, and ease of installation. The company’s integrated platform includes structural foundations, steel frames, electrical balance of systems (eBOS) solutions, and software platforms such as TrueCapture® and NX Navigator, which optimize energy yield and plant operability. Nextpower has expanded into AI and robotics services to improve solar plant deployment and operations. The company serves a diversified customer base across more than 40 countries, with a significant backlog and a global operational footprint. Its business model emphasizes innovation, integrated solutions, and long-term customer partnerships to support the growing demand for clean energy.

Mangoceuticals, Inc. operates in the pharmaceutical and wellness sectors, focusing on compounded pharmaceutical products, nutraceuticals, and telehealth-enabled wellness services. The company relies on a related-party pharmacy, Epiq Scripts, LLC, which provides compounding and pharmacy services across most U.S. states under a Master Services Agreement and Consulting Agreement. Mangoceuticals has expanded its product offerings through acquisitions of intellectual property and entry into new markets such as oral pouch delivery and women's telehealth wellness brands. The company has a limited operating history with recurring net losses and an accumulated deficit. Financial disclosures as of March 31, 2026, show modest revenue and significant net losses, with liquidity ratios indicating a current ratio of 0.29 and cash ratio of 0.24. The company is currently not in compliance with Nasdaq's minimum bid price requirements and has received a notification letter with a compliance deadline in August 2026. Regulatory risks are notable due to FDA scrutiny of compounding pharmacies and telehealth prescribing practices. Mangoceuticals depends on third-party logistics providers and faces risks related to counterfeit products, legal claims, and cybersecurity. The company continues to invest in product development, marketing, and intellectual property to support growth.

James Hardie Industries plc operates as a leading provider of exterior home and outdoor living solutions, with a product portfolio that includes fiber cement siding, trim, decking, railing, and accessories. The company expanded its footprint through the acquisition of AZEK in July 2025, integrating AZEK's environmentally sustainable outdoor living products and manufacturing facilities in the United States. Post-acquisition, James Hardie reports financial results across four segments: Siding & Trim, Deck, Rail & Accessories, Australia & New Zealand, and Europe. The company’s operations are closely tied to the residential and commercial construction markets, which are influenced by economic conditions, housing starts, and remodeling activity. James Hardie faces competitive pressures from various building material manufacturers and must manage risks related to raw material supply, manufacturing efficiency, product quality, and regulatory compliance. The company maintains significant indebtedness and is subject to legal proceedings related to its acquisition activities and product liability matters.

Driven Brands Holdings Inc. operates the largest automotive services platform in North America, with a network of over 4,200 locations spanning 49 U.S. states and Canada. The company’s services cover routine maintenance such as oil changes, as well as collision repair, paint, glass repair, and parts distribution. Its key segments include Take 5 Oil Change, Franchise Brands (including Meineke, Maaco, CARSTAR, and others), and Auto Glass Now. The company’s business model is a mix of franchised and company-operated locations, with a strong pipeline for new franchise openings and greenfield company-operated stores. Driven Brands leverages data analytics to optimize marketing, product offerings, and pricing, and provides shared services to its network to enhance margins and operational efficiency. The company reported approximately $1.86 billion in revenue for fiscal year 2025 and continues to focus on debt reduction and operational cash flow generation.

Corvex, Inc. is a Delaware-based public company trading on Nasdaq under the ticker MOVE. The company completed a merger in March 2026, acquiring Corvex Legacy Holdings, Inc. The leadership team and board comprise individuals with extensive experience in medical devices, technology, AI/ML platforms, and finance. The company reported modest revenue and a net loss for Q1 2026, with liquidity ratios indicating coverage of current liabilities. Equity compensation programs were implemented in 2025 due to liquidity challenges. The company is classified as a smaller reporting and emerging growth company. Specific details on the company's products, services, and industry classification are not explicitly disclosed in the available filings or news.

Doximity, Inc. operates as a physician-first technology platform designed to enhance productivity and patient care for medical professionals. The company has over 3 million registered members, including more than 85% of U.S. physicians, nurse practitioners, physician assistants, and medical students. Its platform provides AI-powered tools such as telehealth, clinical documentation, secure messaging, and an AI assistant for clinical questions. Doximity's business model includes Marketing Solutions for pharmaceutical and health system customers, Hiring Solutions for medical recruiting, and Workflow Solutions to streamline clinical operations. The company leverages network effects to expand its user base and improve its offerings continuously. It maintains a strong focus on HIPAA compliance, data security, and physician-centric design. Doximity also pursues strategic acquisitions to enhance its platform capabilities.

Silexion Therapeutics Corp is a clinical-stage biotechnology company incorporated in the Cayman Islands, specializing in RNA interference (RNAi) therapies for KRAS-driven cancers. Its lead product candidate, SIL204, has demonstrated positive preclinical efficacy in lung and pancreatic cancer models and is progressing towards Phase 2/3 clinical trials. The company has established strategic collaborations, notably with Catalent, to advance manufacturing and development. Silexion has conducted multiple financing rounds and warrant exercises to fund its operations and clinical development. The company maintains effective internal controls and has implemented share capital adjustments to support its growth and capital structure.

Cantor Equity Partners V, Inc. is a Cayman Islands-incorporated company that completed its initial public offering in November 2025, raising $250 million through the sale of Class A ordinary shares. The company simultaneously completed a private placement with its Sponsor. Proceeds from these offerings are held in a trust account pending the completion of an initial business combination. The company operates under the regulatory framework applicable to smaller reporting companies and has disclosed key financial metrics in its recent SEC filings.

Nauticus Robotics, Inc. develops and operates applied robotic solutions with a focus on deep-sea mineral exploration. The company expanded its capabilities through a $16 million asset acquisition in early 2025 and secured substantial equity financing to support growth initiatives. It manages a complex capital structure including convertible debentures and term loans, with recent amendments to loan agreements and equity facilities. The company is listed on Nasdaq and has taken steps to maintain compliance with listing requirements, including a reverse stock split and equity maintenance conditions. Leadership changes include the appointment of an interim CFO and a new Chief Revenue Officer in 2026.

Cantor Equity Partners IV, Inc. operates as a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in 2021. Its primary objective is to identify and complete a Business Combination with a target company, focusing on sectors including financial services, digital assets, healthcare, real estate services, technology, and software. The company completed its IPO in August 2025, raising $450 million, with proceeds held in a Trust Account invested in low-risk securities until the Business Combination is completed. The management team and Sponsor, affiliates of Cantor, bring experience in sourcing, structuring, and executing acquisitions, as well as operating and growing businesses. The company has a 24-month window from IPO to complete the Business Combination, extendable up to 36 months with shareholder approval. If unsuccessful, it will liquidate and redeem Public Shares at Trust Account value. The company currently has limited operations and no full-time employees prior to the Business Combination.

PAVmed Inc. operates as a diversified life sciences company with a focus on medical devices, diagnostics, and digital health through independently financed subsidiaries. Its primary subsidiaries are Lucid Diagnostics, which commercializes the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer and cancer in GERD patients, and Veris Health, which provides the Veris Cancer Care Platform for personalized cancer care and is developing an implantable physiological monitor. PAVmed also develops medical devices such as the PortIO implantable intraosseous vascular access device and licensed endoscopic imaging technology. The company pursues commercialization through multiple channels, including physician targeting, test centers, telemedicine, and strategic partnerships. It actively seeks insurance coverage and reimbursement, including Medicare reconsideration and contracts with the U.S. Department of Veterans Affairs. PAVmed reported a net loss and maintains liquidity with cash and current assets exceeding current liabilities as of March 31, 2026.

Pixelworks, Inc. is a technology company specializing in content creation, video delivery, and display processing solutions aimed at delivering authentic viewing experiences across various screens. Historically, the company operated semiconductor hardware businesses serving Mobile and Home & Enterprise markets. In January 2026, Pixelworks completed the sale of its semiconductor subsidiary, exiting the semiconductor business. Post-sale, the company is focused on cinematic visualization solutions, centered on its TrueCut Motion platform, which provides filmmakers with tools to customize motion appearance and preserve creative intent across distribution and playback. The platform includes software tools, motion grading services, licensing to distributors and device manufacturers, certification services, and brand licensing. Pixelworks holds a portfolio of patents related to video processing technologies. The company reported modest revenue in Q1 2026 but significant net income, supported by strong liquidity. The business model relies on establishing and maintaining relationships across the cinematic content creation and distribution chain. Competition is present from established post-processing and visual effects companies. The company has significantly reduced its workforce following the sale and restructuring.

Summit Networks Inc., incorporated in 2014, historically operated as a development-stage company exploring various business opportunities without sustained revenues. In 2025, it completed a preparatory internal development phase focused on governance and operational frameworks. The company is now in a strategic transition aiming to build a scalable logistics platform through acquisitions of established, revenue-generating logistics enterprises primarily in Asia. Management emphasizes capital-efficient acquisitions, operational integration, and governance standardization. As of early 2026, no acquisition agreements have been finalized. The company maintains a small employee base and relies on external professional services, with plans to expand post-acquisition. Financially, the company reported modest revenues and net losses in 2025, with liquidity challenges and a stockholders' deficit. Governance improvements and regulatory clearance were achieved in early 2026, supporting the strategic transition phase.

FRP Holdings, Inc. is a Florida-based real estate development, asset management, and operating company. It conducts business through wholly-owned subsidiaries and joint ventures, focusing on four segments: Industrial and Commercial, Mining Royalty Lands, Development, and Multifamily. The Industrial and Commercial segment owns and manages warehouses and office buildings primarily in Maryland and Florida. The Mining Royalty Lands segment owns approximately 16,640 acres leased for mining royalties in Florida and Georgia. The Development segment acquires, entitles, and develops land for residential, retail, industrial, and office use, including converting non-income producing lands into income-producing assets. The Multifamily segment manages mixed-use residential and retail properties through joint ventures, including consolidated properties in Washington, D.C. The company’s properties are concentrated in the Mid-Atlantic and Southeastern U.S. Recent strategic moves include acquiring Altman Logistics Properties, expanding industrial development projects, and advancing multifamily and mixed-use developments. The company’s business model includes leasing, property management, development, and royalty income from mining operations.

Oncotelic Therapeutics, Inc. operates in the biotechnology sector with a focus on pharmaceutical manufacturing enhanced by AI and robotics. The company has entered into a joint development and licensing agreement with TechForce Robotics to develop AI-enabled robotic systems for pharmaceutical environments, leveraging its proprietary PDAOAI platform. Oncotelic completed a merger involving intellectual property assets and patent portfolios related to medical countermeasures and therapeutic applications. Financially, the company reported a net loss and limited revenue, with liquidity ratios indicating constrained short-term financial flexibility as of the latest quarter ending March 31, 2026.

Celcuity Inc. focuses on developing targeted therapies for multiple solid tumors, with its lead candidate gedatolisib inhibiting all class I PI3K isoforms and mTOR complexes to comprehensively block the PAM pathway. This mechanism aims to overcome resistance seen with single-component inhibitors. Gedatolisib is administered intravenously and has demonstrated better tolerability compared to oral PI3K or mTOR inhibitors. The company is conducting Phase 3 trials (VIKTORIA-1 and VIKTORIA-2) in hormone receptor-positive, HER2-negative advanced breast cancer, stratified by PIK3CA mutation status, and a Phase 1b/2 trial in metastatic castration resistant prostate cancer. Celcuity holds exclusive rights to gedatolisib under a license agreement with Pfizer and relies on third-party manufacturers for drug supply. The company has not yet commercialized any products and continues to incur operating losses while advancing clinical development and preparing for potential commercialization.

Launch One Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands in February 2024. Its business model is to raise capital through an IPO and then identify and merge with a private company to take it public via a Business Combination. The company raised $230 million in its IPO in July 2024, with proceeds held in a Trust Account. It has not generated operating revenues and focuses on acquiring companies in the healthcare and biotechnology sectors. The management team and board have extensive experience in life sciences and SPAC transactions. The company has until July 15, 2026, to complete its Business Combination or liquidate and return funds to shareholders. It terminated a prior Business Combination Agreement with Minovia Therapeutics in January 2026 and is seeking alternative targets. The company has access to working capital loans from its Sponsor to fund expenses related to the Business Combination process.

Inflection Point Acquisition Corp. III (IPCX) is a special purpose acquisition company incorporated in the Cayman Islands in January 2024. Its primary purpose is to effect a business combination with one or more operating businesses. IPCX completed a business combination with A1R water, a company specializing in atmospheric water generation technology, through a two-step merger process finalized in 2025. The combined company is publicly traded on Nasdaq under the ticker IPCX. The business combination included PIPE investments and structured earnout shares contingent on financial and market performance milestones. IPCX maintains strong liquidity as of the latest quarter and has recently expanded commercial partnerships and distribution agreements for A1R water products.

Bravo Multinational Inc. is a publicly reporting company that has undergone multiple business transformations since its founding in 1989. Historically involved in gaming equipment leasing and mining claims, the company shifted its focus in 2023 to entertainment, hospitality, and technology sectors. It is developing streaming services offering on-demand content accessible across various platforms and has launched a wireless service called My Charity Wireless. The company is also expanding strategically into telecommunications and has signed letters of intent to acquire streaming assets. Leadership includes industry veterans and award-winning executives. Financially, the company has reported no revenue in recent years, with significant net losses and accumulated deficits. It maintains a strong liquidity position in terms of cash relative to current liabilities but faces material weaknesses in internal controls and ongoing operational challenges.

BioForce Nanosciences Holdings, Inc. is focused on developing and marketing natural vitamins, minerals, and nutritional supplements formulated to promote healthier lifestyles for active individuals. The company has not generated revenue from its supplement products in recent years and faces significant financial challenges, including substantial accumulated deficits and liquidity constraints. It relies on external financing to sustain operations and pursue its business plan.

Cyngn Inc. develops autonomous vehicle technology focused on industrial applications, aiming to automate material transport vehicles to address labor shortages, high labor costs, and workplace safety challenges. The company’s core product, DriveMod, is a modular, vehicle-agnostic autonomous driving software stack integrated onto vehicles manufactured by OEMs or retrofitted onto existing vehicles. DriveMod supports indoor and outdoor environments and is complemented by Cyngn Insight for fleet management and analytics, and Cyngn Evolve for AI and machine learning development. Cyngn’s Enterprise Autonomy Suite (EAS) is designed to be a universal autonomous driving solution with minimal marginal cost for customers to adopt and expand autonomous fleets across multiple vehicle types and sites. The company pursues a go-to-market strategy focused on collaboration with OEMs and their dealer networks, and a land & expand approach with end customers deploying heterogeneous fleets. Revenue is generated through deployment projects, subscription licenses, and customization contracts. Cyngn’s technology leverages AI, cloud connectivity, sensor fusion, and real-time path planning to enable level-4 fully autonomous driving without a human driver. The company has commercial deployments with customers including John Deere, G&J Pepsi, and US Continental, and continues to expand its vehicle portfolio and patent portfolio. Financially, Cyngn reported modest revenue and significant net losses for the quarter ended March 31, 2026, with strong liquidity ratios indicating a solid short-term financial position.